SEM 2 SBA Flashcards

1
Q

RAAS

A

-low ECF volume so slow flow through tubule –> more time for reabsorption or decrease in renal perfusion (BP)
-decrease in GFR
-low [Na+] at macula densa
-sympathetic stimulation
-renin released from juxtaglomerular cells
-renin converts angiotensinogen (produced by liver) to
Ang I
-Ang I -> Ang II by ACE (on endothelium of lung vessels)
-Ang II binds to (AT1 receptor - Gq) :
On vascular SM :
-vasoconstriction
-increasing TPR + BP
On adrenal glands :
-stimulates aldosterone release from zona glomerulosa
-aldosterone increases Na+ reabsorption
-water follows with it by osmosis
-increases blood volume –> decreases Na+ in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Macula densa

A

Region of contact between afferent arteriole + distal tubule of same nephron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Juxtaglomerular (granular) cells

A

Modified SM cells along afferent arteriole
Renin secreting
Mechano-sensors - detect BP + blood volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Effect of ANP on renal?

A
  • causes natriuresis (increased Na+ excretion)

- water follows –> diuresis (increased water excretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Effect of ANP on vasculature

A
  • causes vasodilatation of vessels
  • stimulates G pathway
  • stimulates Guanulate Cyclase (GC)
  • produces cGMP from GMP
  • cGMP activates PKG
  • PKG causes vasodilation
  • decrease TPR + BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effect of ANP on horomes

A
  • acts on kidney to decrease renin release
  • reduces Ang II
  • reduces vascular tone
  • ANP reduces aldosterone release
  • ANP inhibits renin release
  • reducing Ang II + aldosterone
  • it inhibits aldosterone directly
  • reduces ADH release
  • to decrease Na + reabsorption
  • to decrease water uptake
  • decreases collecting duct permeability
  • excrete more Na+, decrease blood volume + BP
  • opposes RAAS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pressure natriuresis

A
  • increase renal arterial pressure
  • forcing more Na+ excretion
  • vasoconstriction
  • decreases flow
  • increases pressure drop so Pc constant
  • renal arterial auto-regulation
  • increase in medullary capillary pressure
  • afferent arteriole, glomerulus, efferent arteriole leads to peritubular capillaries
  • higher pressure in peritubular capillaries
  • plasma moves into interstitial space
  • rise in pressure in interstitial area
  • reduces reabsorption of Na+ from tubule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to excrete Na+?

A

Cardiac natriuretic peptides (ANP)

Pressure natriuresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PCT

A
  • Active re-absorption of NaCl (65%), AA, glucose
  • Passive re-absorption of K+, HCO3-
  • Secretion of NH3, drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LOH

A
  • Asecending is H2O impermeable but active re-absorption via Na+/ K+/ 2Cl-
  • Descending is H2O permeable –> salty medulla but low permeability to ions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DCT

A
  • Regulates pH by absorbing HCO3- + secreting H+ into filtrate
  • Aldosterone increases absorption of Na+ and Cl-
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Collecting ducts

A
  • Absorption of Na+ and urea from filtrate

- ADH increases absorption of H2O by inserting aquaporins2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADH

A

-binds to V2 receptor on basolateral membrane
-Gs activates AC intracellular pathway
-increase cAMP
-increase PKA
-ADH causes translocation of vesicles to luminal membrane where aquaporins are inserted
-water flow down osmotic gradient into conc interstitial
tissue (thus blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Countercurrent flow

A

=tubular fluid moves down in descending limb + moving up in other
-on thick ascending limb pumping NaCl out of tubular fluid into interstitial fluid between 2 limbs
-impermeable to water so no water out ascending
-solutes build up in interstitium as you move down
-at bottom intersitium very hyperosmotic
-hyperosmotic gradient
-fluid enters into descending
-fluid osmolality same as plasma (300)
-as it moves down, water leave due to hyperosmotic interstitium pulling water out
-water moves out
-tubular fluid becomes hyperosmotic
-fluid moves down descending becoming more
hyperosmotic.
-fluid moves up
-water trapped as impermeable to water
-osmolality of tubular fluid –> hypoosmotic
-when tubular fluid leaves LoH it’s hypoosmotic (diluter
than plasma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Effect of Na+ not being removed?

A

Wherever Na+ goes water will follow so

  • decreased Na+ removal
  • reduces ECF volume
  • decreases blood volume
  • decreased CO
  • decreased BP + oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Uses of loop diuretics eg Frusemide?

A

Chronic heart failure - low ECF volume, CVP, CO
Acute pulmonary oedema - venodilatation
Acute renal failure - increased renal blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Thiazide drugs eg Bendrofluazide + Chlorothiazide

A
  • blocks Na+/ Cl- at DCT
  • preventing reabsorption of Na+ and Cl- .
  • more Na+ in DCT
  • more water move into tubule
  • some Na+ move into blood again via other transporters
  • transporters working harder
  • ↑K+/H+ excretion at DCT
  • hypokalemia + metabolic alkalosis
  • removing excess Na+ stimulate macula densa
  • increased RAAS
  • more aldosterone
  • Na+ reabsorption
  • ↑K+/H+ excretion
  • -hypokalemia + metabolic alkalosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Thiazide drugs eg Bendrofluazide + Chlorothiazide

A

4*

  • blocks Na+/ Cl- at DCT
  • preventing reabsorption of Na+ and Cl- .
  • more Na+ in DCT
  • more water move into tubule
  • some Na+ move into blood again via other transporters
  • transporters working harder
  • ↑K+/H+ excretion at DCT
  • hypokalemia + metabolic alkalosis
  • removing excess Na+ stimulate macula densa
  • increased RAAS
  • more aldosterone
  • Na+ reabsorption
  • ↑K+/H+ excretion
  • risk of hypokalemia + metabolic alkalosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Uses of thiazide drugs eg Bendrofluazide + Chlorothiazide?

A
  • Hypertension - diuresis causes decreased BV + CO so causing vasodilatation to decrease TPR
  • Heart failure - low ECF volume, CVP, CO
  • Oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Osmotic agents eg Mannitol

A
  • filtered but not reabsorbed
  • high conc increases tubule osmolarity
  • decrease reabsorption of H2O
  • acts at PCT, DCT, collecting duct
  • no effect on electrolyte excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Uses of osmotic agents eg Mannitol?

A
  • Reduce intracranial + intraocular pressure : mannitol doesn’t enter CNS -> creates osmotic gradient –>H2O leaves CNS into plasma
  • Prevent acute renal failure
  • Prevent ANURIA - distal nephron can dry up when filtration is low
  • Excretion of poisoning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Site 1, 2 of PCT

A
  • 1
  • reabsorption of Na+ with passive movement of Cl- + H2O
  • net reabsorption of NaCl + H2O
  • 2
  • exchanging of Na+ and H+
  • carbonic anhydrase makes H+ inside cell by making carbonic acid
  • breaks into H+ and HCO3-
  • H+ out of cell in exchange for Na+
  • HCO3- reabsorbed with Na+
  • H+ + HCO3- in lumen –> carbonic acid
  • dissociate into H2O + CO2
  • CO2 diffuses into cell so HCO3- reabsorbed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Site 3 of LoH

A
  • transport of NaCl by Na+/K+/2Cl-
  • thick ascending limb impermeable to H2O
  • so interstitial region here (in medulla) is hypertonic
  • reabsorption of H2O from collecting duct as it passes via medulla
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Site 4,5,6 of DCT

A
  • 4
  • reabsorption of Na+ and Cl- followed by H2O
  • 5
  • aldosterone increases ENaC channels on luminal membrane and Na+/K+ on basolateral membrane
  • Na+ reabsorbed via ENaC
  • in exchange for K+ efflux into luminal membrane
  • 6
  • Na/H exchanger stimulated by aldosterone

5 + 6 can produce K+ loss (in response to Na

reabsorption) + alkalosis (due to increased proton
excretion) –> hypokalaemia + alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Carbonic anhydrase inhibitors eg Acetazolamide

A

2*

  • mild diuretics
  • inhibit carbonic anhydrase
  • decrease formation of H+ in luminal cells of PCT
  • loss of NaHCO3 into lumen
  • loss of H2O
  • Used in non-renal effects eg glaucoma as aqueous humor formation dependent on CA activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

K + sparing diuretics eg Spironolactone

A
  • 5 + 6
  • competitive antagonist of aldosterone
  • inhibit ENaC channels
  • less Na+ entering cells, reabsorption, inhibit Na+/K+ATPase
  • less Na+ in, less K+ out, losing water
  • Useful in CVS diseases linked to overproduction of aldosterone so volume overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Aldosterone

A

-Steroid hormone synthesised by zona glomerulosa of
adrenal gland
-Released by Ang II on AT1 receptors

-Goes to DCT + collecting ducts
-diffuses via membrane + acts on nuclear receptors
(ligand-activated transcription factors)
-binds to mineralocorticoid receptor
-changes in transcription
-increase in luminal ENaC channel (sodium
channel) + Na+/K+ pump on basolateral membrane
-more Na+ into tubular cells
-increase [Na+] in cell so we increase Na+/K +pumps
-3Na+ out and 2K+ in
-Na+ from tubule lumen into plasma
-water follows
-conserving Na+, water –> increases blood volume + BP
-increased activity of Na+/K+ pump means more K+ taken from blood put into cell and passively secreted into lumen down conc gradient
-K+ excretion
-hyperaldosteronism –> hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What does adrenal gland produce?

A
  • Ouside adrenal gland is capsule
  • Zona glomerulosa producing mineralocorticoid aldosterone
  • Zona fasiculata producing glucocorticoids (primary
    cortisol)
  • Zona reticularis producing sex steroids (weak androgens)
  • Medulla producing catecholamines : A + NA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Liddle’s syndrome

A
  • Rare genetic form of high BP associated with epithelial ENaC
  • changes AA seq of ENaC
  • open more often so increased renal Na+ reabsorption
  • greater Na+ into cell –> blood
  • greater movement of water into plasma
  • increased blood volume + pressure sensed by RAAS system
  • turn off renin release, Ang II, aldosterone release
  • low renin + aldosterone
  • continued increase in blood volume + pressure
  • hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Conn’s syndrome

A

Hypernatremia, hypokalaemia, alkalosis
-Primary hyperaldosteronism by overproduction of
aldosterone from adenoma of zona glomerulosa of adrenal cortex
-unregulated by renin so aldosterone releasing consistently
-increased ENaC so Na+ reabsorption
-increased Na+/K+ATPase driving Na+ into plasma
-water follows
-increase in ECF volume + BP
-JGCs detect BP so decrease renin secretion
-but irrelevant as tumour releasing aldosterone regardless of renin/Ang II
-K+ excretion by Na+/K+ pump due to aldosterone:
*ENaC driving Na+ into cell changes electrical gradient across cell, so K+ move into lumen
*increased permeability of apical membrane to K+
-aldosterone stimulates H+/K+antiport in intercalated cells
-removes H+ into lumen + brings K+ into cell
-however K+ reabsorption less than
-alkalosis + hypokalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Renal artery stenosis

A
  • narrowing of renal artery
  • increased pressure drop across narrowing
  • BP decreased in kidney
  • decreased flow
  • sensed by kidney
  • secretes renin
  • produces Ang II.
  • vasoconstriction of vessels + increase aldosterone
  • increased Na+ retention + water retention
  • high BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Factors that stimulate renin release?

A
  • ↓ BP + BV –> ↓ renal blood flow via afferent arteriole mechanoreceptors
  • ↓ Na at macula densa
  • Symp nerve activation of β1 adrenoreceptors

Due to changes in baroreceptors activity + cardiac volume receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Atrial natriuretic peptide (ANP) + brain natriuretic peptide (BNP)

A

found in specialised cardiac myocytes

released by ↑ cardiac filling pressures (↑ECFV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

vasa recta

A
  • Delivers O2 + nutrients to cells of LoH
  • Permeable to both H2O + salts
  • Could disrupt salt gradient established by LoH so acts as counter-current multiplier system as well
  • vasa recta descends into renal medulla
  • water diffuses out into surrounding fluids
  • salts diffuse in
  • vasa recta ascends - reverse occurs
  • conc of salts in vasa recta same
  • salt gradient at LoH constant
  • water removed to not dilute longitudinal osmotic gradient
  • medullary blood flow in vasa recta is slow
  • sufficient to supply metabolic needs of tissue, but minimize solute loss from medullary interstitium

*Low BF in VR ~5% of renal BF to minimise solute loss from interstitium + maintains medullary interstitial gradient

-reabsorbed Na+ in descending carried to inner medulla equilibrating with interstitial fluid - ↑osmolarity
-Na+ in ascending returns to systemic circulation
-solute in ascending is product of flow rate + conc
If blood flow in VR increases then solutes washed out of medulla+ its interstitial osmolality decreased
If BF decreased - opposite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Amiloride

A

Blocks ENaC at *5

Reduces Na+ reabsorption and K+ loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Captopril

A
  • ACE inhibitor
  • inhibits production of Ang II
  • decrease aldosterone levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Sources of acid?

A

-Metabolism of carbs + fats produces volatile CO2
CO2 + H2O ⇌ H2CO3 ⇌H+ + HCO3-
-Metabolism of proteins produces non-volatile acids
H2SO4 (from S-containing AA) + HCl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

pH control

A

-ICF + ECF buffering systems
-Respiratory system - controls pCO2
-Kidneys - bicarbonate retention or secretion
via
Bicarbonate system
H+ + HCO3- ⇌ H2CO3 ⇌ CO2 + H2O

Phosphate system
H+ + HPO42- ⇌ H2PO4-

Protein system
H+ + Pr- ⇌ HPr
eg H+ + Hb- ⇌ HHb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Resp mechanisms of pH control

A

-chemosensitive area in medulla monitors [H+] based on CO2 that can cross BBB (CSF only buffered by HCO3-)
-plasma pH detected by peripheral chemoreceptors in aortic arch + carotid bodies
-signal to increase/decrease respiratory ventilation
-↓/↑ pCO2
-adjusted pH
H+ + HCO3- ⇌ H2CO3 ⇌ CO2 + H2O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Renal mechanisms of pH control

A
  • formation + “reabsorption” of HCO3-
  • secretion of H+
  • bicarbonate, phosphate, ammonium buffer systems
  • in all systems HCO3- being reabsorbed into blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

PCT controls pH

A

85% HCO3- reabsorbed + secrete H +
(no ATPase)
-HCO3- filtered by glomerulus
-[HCO3-]tubular fluid = plasma
-HCO3- + secreted H+ –> carbonic acid in tubular lumen
-carbonic acid dissociates -> CO2 + H2O
-catalysed by carbonic anhydrase on luminal brush border
-CO2 crosses tubular cell down conc grad
-CO2 recombines + H2O -> carbonic acid via carbonic anhydrase
-carbonic acid dissociates -> H+ and HCO3-
-HCO3- back into blood with Na+ via basolateral Na/HCO3 symporter
-H+ back into tubular fluid in exchange for Na+
-H+ appear in urine as water so urine pH unchanged
-net result = reabsorption of HCO3-, slight fall in tubular pH, no change in PCO2 of tubular fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Late DCT + collecting duct control pH

A
  • in intercalated cells of late DCT + collecting duct
  • H+ATPase pump vital
  • H+ pumped in
  • pH drops by end of collecting duct
  • low [HCO3-] as most reabsorbed
  • so H+ react with other buffers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Phosphate buffer

A
  • phosphate ions poor buffers in ECF due to low conc but when filtered at glomerulus, phosphate exceeds Tm
  • excess phosphate gets conc
  • further secretion of H+ into lumen buffered by HPO42-
  • effective buffer due to pK = 6.8 (close to pH of filtrate) + lipid-insoluble from –ve charge even after accepting H+ so can’t carry it back into blood
  • H+ATPase pumps H+
  • binds to mono-hydrogen phosphate + accepts it readily
  • phosphate retains a –ve charge so traps H+ in urine
  • HCO3- enters back into blood via antiporter with Cl-
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Ammonium buffer

A
  • tubular epithelium produces NH3 from glutamine with glutaminase
  • glutamine broken down -> 2NH3 + α-ketogluterate
  • α-ketogluterate broken down in TCA cycle -> 2 carbonic acid molecules
  • dissociate -> 2H + and 2HCO3-
  • H+ and NH3 -> NH4+
  • sent into urine via antiport with Na+
  • HCO3- back into blood with Na+
  • NH4+ excreted into lumen acts as buffer for excess H+
  • replenish ECF + ICF pools
  • NH4+ secreted as ammonium salts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Role of phosphate + ammonium buffer?

A

prevent acidic urine

ammonia produces new bicarb to replenish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Respiratory acidosis

A

Alveolar hypoventilation

  • eg obstructed airways
  • CO2 accumulates
  • ↑pCO2
  • ↓pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Respiratory alkalosis

A

Hyperventilation

  • (eg anxiety)
  • fall in CO2
  • ↓pCO2
  • ↑pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Metabolic acidosis

A

Excessive production of acid by organs or exogenous acids

  • (eg diabetic ketoacidosis)
  • erxcessive loss of HCO3- from GIT from diarrhoea
  • failure of acid excretion by kidneys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Metabolic alkalosis

A

Excessive ingestion of alkaline antacids
Excessive loss of H+ from GIT from vomiting
Excessive diuretic (thiazide) use
Chronic loss of Na+, K+, Cl- –> H+ secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Diabetic ketoacidosis

A
  • Type I (enough insulin production in type 2 to avoid DKA)
  • Excessive ketone production.
  • Osmotic diuresis; glucose in urine –> water following by osmosis so dehydration + loss of electrolytes –> renal failure
  • Form of metabolic acidosis
  • body can’t glucose due to lack of insulin
  • starvation state
  • fat breakdown for energy
  • producing ketones
  • fruity breath
  • ‘Breathing deeply’= Kussmaul breathing (deep freq breaths)
  • reflex to stimulate CO2 loss from lungs to balance metabolic disturbance
  • initial breathing response to metabolic acidosis is fast + shallow
  • overtime deep, laboured, gasping = kussmaul breathing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Potassium balance

A
  • Determines ICF osmolality, cell volume, ECF volume
  • Affects vascular resistance by affecting polarisation of vascular SM cell)
  • For heart + skeletal muscle cells
  • Affects vascular resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Hyperkalaemia

A
  • more K+ outside cell
  • diff between K+ in cell vs outside cell
  • RMP less negative
  • more depolarised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Hypokalaemia

A
  • less K+ outside
  • huge diff
  • outside less positive
  • RMP more negative
  • hyperpolarised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Factors that move K+ in/out cell

A

IN:insulin, aldosterone, β-adrengic stimulation, alkalosis
OUT:DM, Addison’s (aldosterone def), β-adrengic blockade, acidosis, cell lysis, exercise, increased ECF osmolarity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Causes of hyperkalaemia

A
  • Acute (after prolonged exercise)
  • Long term use of K+ sparing diuretics
  • Addison’s disease
  • Increased release from damaged body cells during chemo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Effect of hyperkalaemia

A

Plasma [K+]>7mM –> asystolic cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Treatment of hyperkalaemia

A

Insulin/Glucose infusion to drive K+ back into cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Causes of hypokalaemia

A

-Long-standing use of K-wasting diuretics
(thiazide + loop diuretics)
-Hyperaldosteronism / Conn’s Syndrome
-Prolonged vomiting (indirectly via Na+ loss)
-Profuse Diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Effect of hypokalaemia

A

↓ release of A, insulin, aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Treatment of hypokalaemia

A

Oral/IV K+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

PCT ion reabsorption

A
  • 60-70% of Na+ and K+ reabsorbed
  • Constant fraction, amount reabsorbed changes with GFR
  • Passive + paracellular transport via tight junctions
  • K+ channels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

LoH ion reabsorption

A
  • 90% of filtered K+ reabsorbed in PCT + LoH
  • Ascending impermeable to water
  • Thick ascending limb contains Na/K/2Cl cotransporter that works by secondary active transport
  • Water leaves in descending limb + ions leave in ascending limb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

DCT + collecting duct ion excretion

A
  • Excretion of K+ via principal cells of late DCT + CD
  • Na+/K+ ATPase on basolateral membrane
  • K+ high in cell so diffuses into blood
  • K+ channel at luminal membrane
  • ENac - aldosterone sensistive
  • increased Enac
  • Na+ flows in so K+ out into lumen
  • more Na+ reabsorbed by principle cell
  • more K+ secreted
  • also K/Cl symporter on luminal membrane moving K+ out

3 determinants of K secretion control:

1) activity of Na-K-ATPase pump
2) electrochemical gradient
3) permeability of luminal membrane channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What determines K+ secretion?

A

K+ intake
Blood pH
Tubular flow rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

How does aldosterone affect K+ secretion?

A
  • Increased synthesis + activity of Na/K-ATPase at basolateral membrane = 3Na out, 2K+ in, build up inside then move out
  • Upregulates epithelial ENaC at luminal membrane = Na+ in, K+ out
  • Increased permeability of luminal membrane to K+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

How alkalosis affects K+ secretion

A
  • increase pH
  • increase in Na+/K+ ATPase activity
  • ↓plasma [K+]
  • hypokalaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

How acidosis affects K+ secretion

A
  • low pH
  • increased plasma [H+] inhibits Na+/K+ ATPase at basolateral membrane
  • less K+ secreted
  • hyperkalaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

How tubular flow rate affects K+ secretion

A
  • higher rates of distal tubular flow
  • increases K+ secretion
  • rapidly washed away
  • low [K+] tubular fluid
  • increases [K+] gradient :)
  • ADH stimulates K+ conductance of luminal membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Addison’s disease

A
Hyponatremia, hyperkalaemia, acidosis, low cortisol + aldoesterone
=Primary adrenal insufficiency
-adrenal glands produce insufficient cortisol + aldosterone
-body secreting more Na+
-low serum Na+
-body retaining K+ 
-hyperkalemia
CAUSES : autoimmune, TB, CAH
EFFECTS : Anorexia/weight loss, hyperpigmentation due to excess ACTH
TREATMENT : 
Hydrocortisone - (replaces Cortisol)
Fludrocortisone - (replaces Aldosterone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Secondary adrenal insufficiency

A
  • pit gland produces no adrenocorticotropin (ACTH) -common
  • ACTH stimulates adrenal glands to produce cortisol
  • Low ACTH output
  • low cortisol production
  • adrenal glands shrink due to lack of ACTH stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Bladder

A

Transitional epithelium
Impermeable to salt and water
Permeable to lipophilic molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Sphincters

A

Internal – smooth muscle, involuntary control

External – striated muscle, voluntary control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Sensory innervation of bladder

A
  • Pelvic nerve (S2-4) – para
  • small myelinated Aδ Fibres (stretch + volume receptors)
  • unmyelinated C fibres (pain from overstretching)
  • Hypogastric nerve (T11-L2) – symp
  • nociceptive C fibres
  • Pudendal nerve (S2-4) – somatic
  • nociceptive C fibres
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Motor innervation of bladder

A
  • Pelvic nerve (S2-4) – para
  • contract detruser via Ach (mus R) + ATP (purigenic R)
  • relax internal sphincter via NO (cGMP) + Ach (nicotinic R)
  • encourages micturition
  • Hypogastric nerve (T11-L2) – symp
  • relax detrusor indirectly via NA (α-R) + directly via NA (β-R)
  • contract internal sphincter via NA (α-R)
  • inhibits micturition
  • Pudendal nerve (S2-4) – somatic
  • no effect on detrusor
  • contract external sphincter via tonic release of Ach (on nicotinic R)
  • inhibits micturition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Receptive relaxation

A
  • Bladder empty
  • sphincters closed
  • tonic activity of symp + somatic nerves
  • low bladder pressure
  • Arrival of urine
  • detrusor relaxes progressively
  • symp activity inhibits paras transmission
  • little increase in pressure
  • sphincters still closed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Micturition reflex

A
  • bladder starts to fill
  • Aδ fibres sense stretching
  • bladder is full
  • internal sphincter relaxes
  • urine flows into urethra
  • flow of urine into urethra activates pudendal afferents
  • tonic contraction of external sphincter removed by inhibition of somatic input

Modified by voluntary control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Incontinence

A

Stress = pelvic floor injury
Urge = detrusor instability
Neuropathic = head, spinal, peripheral nerve injury
Anatomical = vesicovaginal fistula
Atonic- overflow
Automatic- destruction of spinal cord: unannounced emptying
Neurogenic- freq + uncontrolled (inhibiting signals get interupted)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Treatments of incontinence

A
  • Antimuscurinics to relax detrusor so less spasms of detrusor
  • Bladder retaining (Kegel’s exercises ) to strengthen pelvic floor
  • Botox toxin for spastic urethra
  • Sacral nerve stimulation to re-establish micturition reflex
  • Stem cells / 3D printed bladder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Effect of ions on cardiac contractility

A

Alkalosis: Increases contractility
Acidosis: Decreases since H+ competes with Ca2+ for binding sites on troponin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Effect of ions on calcium binding

A

H+ competes with Ca2+ ions for protein binding

  • Acidosis: hypercalcaemia
  • Alkalosis: less H+, more Ca2+ bound to proteins so hypocalcaemia
  • muscle contraction dependent on intracellular Ca2+ not extracellular.
  • hypocalcaemia refers to decreased extracellular Ca2+
  • Ca2+ affects Na+ channel function at neuronal membranes
  • plug it during Na+ influx
  • modulating its permeability + excitability.
  • in hypocalcaemia insufficient Ca+ blocks channel
  • more Na+ influx
  • destabilise membrane potential
  • increased neuronal excitability leading to tingling, tetany
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Role of kidney?

A

Control volume and composition of body fluids
Remove waste material from body (e.g. Urea)
Acid-Base Balance
Act as endocrine organ – EPO (controls RBC content), renin, produce active form of vit D 1α-hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Constrictions of ureter

A

-Junction of ureter and renal pelvis
-Cross ext. iliac/pelvic brim
-Passage via wall of bladder
Retroperitoneal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Anatomy of kidney

A
  • pyramids+medulla = parenchyma - functional portion of kidney
  • within parenchyma 1 million microscopic nephrons
  • filtered fluid from nephrons drain into papillary ducts
  • drain into minor + major calyces
  • filtrate becomes urine
  • Nephron = functional unit, made up of glomerulus + tubule
  • Types of nephrons : cortical + juxtamedullary
  • Cortical nephrons lie in cortex (85% of nephrons), have short LoH which work during normal conditions
  • Juxtamedullary nephrons have long LoH which work during periods of high activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Ultrafiltration

A
  • Forms glomerular fluid (passive ultrafiltrate of plasma where proteins + complete cells filtered out)
  • Passive process driven by net pressure drop across glomerular membrane
    1) Fenestrated capillary endothelium
    2) Glomerular basement membrane = basal lamina (thick + fused), has holes with negative charges so anything dissolved in water (Na+) can pass through but RBCs can’t due to negative charges (unless barrier breaks down)
    3) Podocytes surround capillaries of glomerulus that have 4nm filtration slits, enclose, strengthen vessels, allows them to withstand large filtration pressures

Filtration slits 4nm allowing small NaCl, glucose, urea not albumin so remain in blood
Nephrotic syndrome has appearance of protein in urine (proteinuria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Starling’s principle

A
Fluid movement due to filtration across wall of capillary dependent on balance between hydrostatic + oncotic pressure gradient across capillary
REVISED 
Jv = LpA  {  ( Pc - Pi )  -  σ(πp - πg)  }
Jᵥ: net filtration 
Lₚ: Hydraulic conductance of endothelium, how Leaky endothelium is 
σ: reflection coefficient for intercellular gaps 
A: wall area
Hydrostatic pressures :
Pc : capillary BP
Pi : interstitial fluid pressure
Osmotic pressures :
πp = plasma proteins
πi = Interstitial proteins
πg = Glycocalyx proteins
(P꜀ - Pᵢ): hydraulic pressure diff 
(πₚ - πᵢ): osmotic pressure diff
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Hydrostatic pressure

A

pushing force by capillary pushing fluid into bowmann’s capsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Oncotic pressure

A

pulling force by capsule also exerting pressure onto capillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Starling force balance reversed

A

in peritubular capillaries BP falls below colloid pressure (due to protein being more conc in plasma) so greater force driving fluid back from tubule into capillary

  • small amount of urine remaining in tubules
  • along tubule, BP in afferent arteriole higher than colloid pressure when enter glomerulus
  • net filtration pressure out of capillaries into tubule
  • in efferent arteriole, pressure drops
  • colloid pressure rises as fluid lost from capillaries
  • so protein more conc –> exerting greater force driving fluid back from tubule into capillary
  • so fluid being reabsorbed back into surrounding tissue + peritubular capillary where it comes into contact with tubule wall/nephron
  • most reabsorbed otherwise volume depleted
  • remaining in end is urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

GFR

A

=how much filtrate removed from blood each min NOT how much blood passes through glomerulus each min
Glomerular filtrate = same composition as plasma except protein free + no cellular components eg RBC
GFR ≈120ml/min
GFR ≈180L/day so plasma filtered 60 times daily
-Affected by hydrostatic, oncotic pressure, permeability of capillary filtration barrier, SA
-Indicator of renal function
-Fast filtration rate coupled with many nephrons so functions with only 1 kidney + reduced function in that kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

GFR intrinsic control - autoregulation

A

Ensure renal plasma flow (RPF) + GFR constant with acute changes in BP
-Bayliss Myogenic Response: F = ∆P/R
Direct vasoconstriction of afferent arteriole with increase in perfusion pressure
-Tubularglomerular feedback TGF
Flow dependent signal detected in macula densa which alters tone (causes contraction) of afferent arteriole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Bayliss myogenic response

A

-Prevents BF during changes in BP
-Vital in renal, coronary, cerebral circulation
F = ∆P/R
F : BF, ∆P : change in pressure, R : resistance
When you increase perfusion pressure in kidney, you get short + brief increase in vessel radius so blood flow rises briefly but as smooth muscle stretches in afferent arteriole, it quickly constricts, reducing flow to normal :

  • increase in perfusion pressure
  • immediate increase in vessel radius (few seconds)
  • blood flow rises briefly
  • stretch on smooth muscle in afferent arteriole
  • results in contraction
  • reduction in diameter
  • increase in resistance
  • flow returns to control value in 30secs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Tubularglomerular feedback

A

GFR increases, so increased fluid flowing through tubule, fluid flows pass macula densa, change [NaCl] in luminal fluid, change osmolality so sensed by macula densa + juxtaglomerular cells, send signals to constrict afferent arteriole, change resistance of afferent arteriole. Outcome is to constrict afferent arteriole, so with increase flow, change in osmolality + [NaCl], elicits signal of ATP release from macula densa cells to activate JG cells –> increased resistance of afferent arteriole so decreased GFR :

  • changes in flow alters luminal [NaCl]+luminal osmolality
  • increase flow rate past macula densa
  • macula densa detects change luminal osmolality
  • renin released from juxtaglomerular cells of macula densa -vasoconstraction of afferent
  • increased resistance in afferent
  • decrease in hydrostatic pressure in glomerulus
  • GFR decreases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

GFR: extrinsic control – renal symp nerves

A

Renal symp nerves reduces GFR by resetting autoregulation to lower level
Occurs in:
Standing upright (orthostasis)
-Heavy exercise
-Haemorrhage and other forms of clinical shock
PURPOSE: Conserve body fluid volume
Symp aided by circulating vasoconstrictor hormones eg A, Ang, ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Excretion rate equation

A

= GFR – reabsorption rate + secretion rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Measuring GFR

A
  • Select substance that’s only filtered + not absorbed, secreted, metabolised
  • Perfect standard is Inulin
  • Rate of filtration through glomerular membrane = Rate of entry into bladder
  • Inulin: inert polysaccharide freely filtered through glomerular membrane, not reabsorbed, secreted, metabolised but :
  • prolonged infusion
  • repeated plasma samples
  • difficult routine clinical use
  • Clinically use creatinine for GFR measurement but varies with muscle mass plus no infusion needed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Measuring eGFR

A

=estimated Glomerular Filtration Rate
Simple - requires one blood test but :
*sig error possible (especially for extremes)
*invalid for pregnant women (25% lower creatine), children, racial groups
-CKD Stages 1-5
-End stage CKD GFR <15 or on dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Clearance

A

=plasma volume that’s completely cleared of substance by kidney per unit of time (ml/min)
-Inulin Clearance= 125ml/min = GFR
-Clinically creatinine is used
-Intrinsic inert substance, released at steady level from plasma, no infusion required, not reabsorbed but some secreted into tubule
-Creatinine clearance = 150ml/min
-However use of antibiotic Trimethoprim is competitive inhibitor of creatinine, competes with Crn for same transporters that secrete Crn from tubular blood into urine –> increase in serum levels of Crn
-Cs = (Us x V)/Ps
V
: urine flow rate
Because inulin not reabsorbed, secreted, metabolised it varies with muscle mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Renal plasma flow

A

= (amount of PAH in urine per unit time) / (diff in PAH conc in renal artery or vein)
Normal value is 660ml/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Leaky podycyte

A
  • loss of protein from blood
  • less capillary oncotic pressure
  • less fluid moving form ECF into blood
  • nephrotic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Where does insulin act

A

Liver: glycogenesis, glycolysis, lipogenesis
Muscle: glucose uptake, AA uptake, glycogenesis
Adipose tissue: glucose uptake, FFA uptake, lipogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Secretions of Islets of Langerhans?

A

insulin (β cells 65%)
glucagon (α cells 20%)
somatostatin (δ cells 10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Insulin precursors

A

Cleaving of C peptide = insulin from pro-insulin
Cleaving of signal seq = pro-insulin from pre-pro-insulin

  • insulin polypeptide is originally pre-pro-insulin
  • signal seq cleaved off –> proinsulin
  • C peptide cleaved off –> insulin
  • insulin receptor is tyrosine kinase
  • becomes phosphorylated when activated
  • activates further signaling pathways :
  • inserting glucose transporters into membrane + glycogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Phosphorylation of tyrosine kinase receptor

A

type of insulin receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

ATP after large meal –> insulin

A
  • β cell membrane has GLUT transporters
  • glucose diffuses into cell
  • glucose enters glycolysis + TCA cycle producing ATP
  • ATP closes ATP sensitive K channels
  • K+ can’t leave
  • cell depolarises
  • vgcc open
  • Ca2+ enter
  • exocytosis of insulin vesicles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Glucagon

A

Acts on liver to antagonise insulin

Stimulates: gluconeogenesis, glycogenolysis, ketogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Glucagon synthesis

A
  • peptide hormone starts as pro-glucagon
  • cleaved to glucagon in α-cells
  • pro-glucagon gene processed to give diff products GLP-1
  • GLP-1 produced in lower intestine
  • GLP-1 increases insulin secretion
  • GLP-1 binds to receptors on β-cells
  • leads to closure of K channels
  • depolarises membrane
  • aactivates vgcc
  • exocytosis of insulin containing vesicles
  • GIP not from proglucagon, but similar effects to GLP-1
  • GIP released in upper small intestine
  • GIP slows rate of gastric emptying
  • potentiates insulin’s response to glucose especially after sugary/fatty meal
  • both GLP-1 + GIP are incretins
  • rapidly degraded by DPP-4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Prediabetes

A

Fasting blood glucose limit: 7 mmol/l
Random blood glucose limit: 11.1 mmol/l
Fasting levels high but not high enough for diabetes: impaired fasting glyceamia
Random levels high but not enough for diabetes: impaired glucose tolerance
Oral glucose tolerance test tests fasting levels then gives patients 75g of glucose + tests levels 2 hrs later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Diabetes

A

Type 1:
-β-cell destruction (due to autoimmune destruction) so no insulin production
-Develops in kids + young adults
-Genetic factors: HLA haplotypes DR3 + DR4
-Environmental factors: viruses, stress, drugs, toxins
-Treatment : ideal = pancreas/β-cell transplant
Type 2:
-β-cell dysfunction –> insulin deficiency
-Linked to insulin resistance
-Develops >40 yrs
-Common in: Indians, afro-caribbeans, high BMI
-Treatment: Insulin sensitisers+drugs to increase insulin production

109
Q

HHS/HONK

A
  • In Type II
  • Develop symptoms of dehydration + high blood glucose levels
  • Can be fatal
110
Q

Micro vs macrovascular complications

A

MICRO
Retinopathy–damage to retina eventually –> blindness
Nephropathy–damage to nephrons –> renal failure
Neuropathy–damage to peripheral neurones so pins, needles, burning, tingling, loss of sensation –> amputations
MACRO = accelerated atherosclerosis as excess glucose breaks down endothelium
Heart attack–MAJOR RISK in diabetics
Stroke/TIA
Peripheral vascular disease–atherosclerosis in peripheral arteries causes reduced blood supply to feet

111
Q

Mechanism of Thiazolidnedione

A

type of Glitazones – INSULIN SENSITISER

Bind to PPAR-gamma receptors to promote FA uptake

112
Q

Mechanism of Gliclazide

A

type of Sulfonylurea
Blocks K+ATPase channels –> increase insulin production
Main side effect: HYPOGLYCAEMIA

113
Q

Mechanism of Metformin

A
INSULIN SENSITISER 
Decrease hepatic glucose output
Increase insulin R
Increase GLUT4 expression
Increase glycogen storage
114
Q

ENS

A

-Digestive system’s own local neuronal complex.
-Lies entirely within in the gut
-Contains 100 million neurones
-Sub-branch of ANS, containing both symp +para nervous control
-Major functions:
Control of motility
Regulation of blood flow
Regulation of gastric + pancreatic secretions
Regulation of GI endocrine cells
Defence reactions

115
Q

Myenteric plexus (Auerbach’s)

A
  • Located between longitudinal + circular layer of muscles

- Control digestive tract motility

116
Q

Submucosa plexus (Meissner’s)

A
  • Located within submucosa of intestinal wall
  • Senses changes within lumen
  • Regulates GI blood flow
  • Controls epithelial cell function
117
Q

Symp vs para of GIT

A
-Symp nervous control (NA) 
Inhibition of GI secretions
Inhibition of motor activity
Contraction of sphincters
Contraction of blood vessels
-Para nervous control (ACh)
Promotion of GI secretions
Promotion of motor activity
Relaxation of sphincters
Relaxation of blood vessels
118
Q

Cause of Gastro-Oesophageal Reflux Disease GORD

A
  • Regurgitation of acidic contents via LOS into lower oesophagus
  • Acid injures oesophagus –> inflammation
  • Occurs when defect in anti-reflux barrier :
  • LOS (closes after bolus passes)
  • Abdo pressure acting on intra-abdo parts of oesophagus
  • Pinchcock effect of diaphragm on oesophagus
  • Oblique angle between oesophagus + stomach
  • Plug-like action of mucosal folds (occludes lumen of gastro-oesophageal junction)
119
Q

Swallowing

A
  1. Buccal:
    - moistening food with saliva
    - breaking down food via mastication
    - formation of bolus
    - pushed backwards towards oropharynx
  2. Pharyngeal
    - moves bolus from oropharynx -> oesophagus
    - controlled by vagus via Ach on Nic receptors
    - UOS relaxes
  3. Oesophageal
    - from oesophagus to stomach by peristalsis - initiated by swallowing + passes right throughout
    - secondary peristalsis- initiated by local distension from distension point stomach
    - LOS relaxes
120
Q

Risk factors of GORD

A
  • Obesity : extra pressure on stomach + diaphragm –> reflux
  • Peptic ulcers –food doesn’t move from stomach to small intestine efficiently –> reflux
  • Hiatal hernia : (akadiaphragmatic hernia) weaks LOS –> reflux
  • Pregnancy : progesterone loosens LOS, foetus exerts pressure on stomach –> reflux
  • Diabetes : patients also have gastroparesis, stomach takes longer to empty so contents of stomach –> reflux (also occurs in people whose stomach nerves and/or muscles unfucntional)
  • Asthma : continuous coughing + pressure in lungs, medications loosen LOS –> reflux
  • Connective tissue disorders: thicker muscular tissues keep stomach muscles from relaxing + contracting properly –> reflux
  • Zollinger-Ellison syndrome: high levels of stomach acid from pancreatic or small intestine tumour (gastrinoma) –> reflux
  • Smoking, alcohol, coffee
121
Q

Complications of GORD?

A
  • Acid regurgitation - water brash
  • Oesophagitis
  • Barrett’s Oesophagus
  • Adenocarcinoma
  • Oesophageal stricture (fibrosis) : lining of oesophagus continuously damaged by acid refluxing into it, scar tissue forms, builds up –> narrowed oesophagus so swallowing difficult + painful
  • Bleeding (peptic ulcer may bleed)
122
Q

Treatment of GORD

A
  • Lifestyle : reduce risk factors, modulate exacerbation
  • Pharmacological :
  • antacids eg CaCO3 (Pepto Bismol) Mg(OH)2
  • H2 receptor antagonists (Ranitidine [Zantac]+ Famotidine [Pepcid]
  • PPI (Omeprazole [Prilosec])
  • Metoclopramide (anti-emetic)
  • Surgical : fundoplication
123
Q

Mechanism of Ranitidine

A
  • after meal
  • gastrin produced by gastric parietal cells
  • stimulates release of histamine
  • binds to H2 receptors
  • secretion of gastric acid
  • Reduces secretion of gastric acid by reversible binding to H2 receptors
  • inhibition of histamine binding to this receptor
  • reduction of gastric acid secretion
  • relief felt 60 mins + last 4-10 hrs so fast, effective symptomatic relief
  • Decreased gastric acid secretion
  • Reduced gastric volume
  • Reduced [H+]
124
Q

Achalasia

A
  • Rare disease of muscle of the lower oesophageal body + LOS
  • Impaired relaxation of sphincter, no contractions, peristalsis of oesophagus.
  • Cause: unknown but degeneration of oesophageal muscles + nerves of myenteric plexus (motor supply of GIT) that control muscles
  • Increased tone of LOS so can’t relax –> no peristalsis
  • Affects mainly SM
  • Abnormal function of LOS from impaired nonadrenergic, noncholinergic (NANC) inhibitory input
  • Symptoms :
  • Backflow (regurgitation) of food.
  • Chest pain, which may increase after eating, or may be felt as pain in the back, neck, and arms.
  • Cough
  • Dysphagia
  • Heartburn.
  • Unintentional weight loss
  • Complications : recurrent lung infections, oesophageal cancer,weight loss
  • Diagnosis :
  • via barium fluoroscopy
  • manometry
125
Q

Management of achalasia

A
  • Endoscopic balloon/ Pneumatic dilation of LOS (+PPI)
  • Heller’s cardio myotomy
  • Fundoplication
  • Peroral endoscopic myotomy
  • Botox (botulinum toxin type A) as muscle relaxant
  • Calcium channel blockers/nitrates
126
Q

Mechanism of metoclopramide

A

-blocks D2 receptors (also excites 5-HT4)
-increased gastric motility + emptying
-increases ACh release
-increases LOS + gastric tone
-increased intragastric pressure
-improved coordination + emptying
Prevents nausea + vomiting triggered by most stimuli
Increases LOS tone
Increases peristalsis of duodenum + jejunum, tone + amplitude of gastric contractions
-Relaxes pyloric sphincter + duodenal bulb
-Gastroprokinetic effects so useful in treatment of gastric stasis
Indications: GORD, nausea due to surgery or cancer (chemo)

127
Q

Role of dopamine in GIT

A
  • Promotes relaxation of LOS + stomach
  • Inhibits gastroduodenal coordination
  • Increases ACh release
128
Q

Mechanism of antispasmodic agents eg propantheline, mebeverine

A

-Musreceptor antagonist
-inhibits PSNS activity
-bowel relaxes
-reduces bowel spasm
Indications: IBS, diverticular disease (which may cause abdo pain)

129
Q

Functions of stomach

A
Reservoir
Digestion
Mixing and mechanical disruption of food
Kill pathogens
Exocrine secretions
Endocrine secretions
Paracrine secretions
130
Q

Parietal/oxyntic cells

A
  • Located in fundic, cardiac, pyloric
  • Stimulated by :
  • Histamine - H2 via cAMP
  • Ach - from para via vagus+ ENS stimulating M3 via Gq
  • Gastrin - CCK2 receptors –> histamine secretion by ECL cells
  • H+ formed from dissociation of H2O
  • Produces HCO3- and H+
  • HCO3- exchanged for Cl- on basal side of cell
  • K+ and Cl- diffuse into canaliculi
  • H+ pumped out of cell into canaliculi in exchange for K+ via H+/K+ATPase pump
  • cellular export of H+ means gastric lumen is highly-acidic environment for digestion by promoting denaturing of ingested proteins
  • Also produce INSTRINSIC FACTOR for absorption of vit B12 (or else def –> megaloblastic anemia)
131
Q

Clinical sig of acid?

A

Peptic ulcers

  • Antacids enhance natural tolerance of gastric lining
  • Antimus eg pirenzepine or H2 antihistamines reduce acid secretion
  • Proton pump inhibitors PPI more potent at reducing gastric acid production since it’s final common pathway of all stimulation of acid production
132
Q

Chief cells

A
  • Produce pepsinogen, gastric lipase, chymosin
  • Stimulated by vagus + acid
  • Converted into pepsin by HCl
133
Q

Enterochromaffin (ECL) cell

A
  • Located in fundic
  • Produces histamine
  • Stimulated by gastrin + vagus
134
Q

Enteroendocrine (APUD) cells

A
  • Located in fundic, cardiac, pyloric

- Producesgastrin, histamine, endorphins, serotonin, cholecystokinin, somatostatin

135
Q

G cells

A
  • Produces gastrin
  • Directly stimulate gastric acid production
  • Also stimulates histamine release
  • Innervated by vagus
136
Q

D cells

A
  • Produces somatostatin

- Inhibit gastric acid production

137
Q

Phases of gastric secretion

A
  1. Cephalic :
    - triggered by thought, sight, smell of food
    - transmitted by vagus
    - acts on G + parietal cells to increase secretions
    - responsible for 20% of gastric secretion
  2. Gastric :
    - stomach distension
    - stimulates secretion
    - responsible for 60% of secretions
  3. Intestinal :
    - presence of fat, acid, protein in duodenum triggers release of secretin
    - decreases gastric acid secretion
138
Q

Peptic ulcers

A
  • Develops in lining of stomach, lower oesophagus, small intestine due to :
  • Chronic NSAID use - reduce conc of prostaglandins in stomach which protect mucosa so erosion + damage
  • H. pylori - causes chronic inflammation (gastritis), 80% of people with H. pylori infection are asymptomatic
  • Complication of GORD
  • Develop from imbalance between factors promoting mucosal damage vs mechanisms promoting gastroduodenal defence
  • Gastric acid, pepsin, H. pylori, non-steroidal anti-inflammatory drug use) vs (prostaglandins, mucus, bicarbonate, mucosal blood flow)
  • Aims of treatment:
  • Reduce acid secretion with H2 antagonist
  • Neutralize acid with antacids
  • Remove H. pylori
  • H2 receptor antagonists eg ranitidine, cimetidine
  • inhibits histamine-stimulated gastric acid secretion *reduces pepsin secretion
  • reduces basal + food-stimulated acid secretion
  • Antacids eg aluminum hydroxide, magnesium carbonate
  • neutralise gastric acid
  • increase gastric juice pH
  • More effective in treating duodenal ulcers
  • Alginates added (forms layer above gastric acid to prevent acid reaching oesophagus)
139
Q

H. Pylori

A

-Uses flagella + adhesins to adhere to mucosa
-Produces urease - converts urea -> NH3 + CO2 to buffer HCl
-Detected by urease test
-Patients swallow radioactively labelled urea
10-30mins later, if radioactive CO2 detected then presence of urease
-Stool test for antibody/antigen
-Treatment triple therapy:
*2 Antibiotics eg amoxicillin, metronidazole
*PPI eg Omeprazole, lanzoprazole, rabeprazole :
inactive at neutral pH, irreversibly blocks H+/K+-ATPase pump to reduce basal + food-stimulated gastric acid secretion
*Bismuth chelate can added

140
Q

Diarrhoea

A
  • Abnormal passage of loose, liquid stools > 3x, 200g/ daily
  • Causes: infectious agents, toxins, anxiety, drugs, ulcerative colitis, crohn’s disease
  • Main mechanism:
  • increased motility of bowels + secretion
  • decreased absorption
  • loss of fluid, electrolytes, nutrients, HCO3-
  • hypovolaemia (dehydration) + metabolic acidosis
  • Dysentery: painful bloody, mucusy diarrhoea
  • Aims of treatment :
  • Maintain body fluids + electrolytes
  • Antibiotics eg erythromycin for Campylobacter jejuni
  • Modify secretion/ absorption balance
  • Treatment :
  • Anti-motility drugs (↓movement + secretion) eg loperamide
  • Anti-spasmodics (↓movement) eg propantheline, mebeverine
  • Antibacterials (often not needed)
141
Q

Mechanism of Loperamide

A

Opioid receptor agonosist

  • binds to peripheral 𝜇-opioid receptors
  • spasmolytic agent reduces SM activity in GIT so reduces passage of faeces
  • inhibit bowel function
  • selective on GIT
  • decreases passage of faeces + duration of illness
  • For diarrhoea
142
Q

Codeine + loperamide

A
  • Anti-secretory action

- ↓ intestinal motility for diarrhoea

143
Q

Bismuth subsalicylate

A
  • ↓ fluid secretion in bowel for diarrhoea
  • Safe for young children
  • May cause tinnitus + blackening of stool
144
Q

Constipation

A

-Bowel movements infrequent or hard to pass
-Causes:
*Reduced motility of large intestine eg elderly, (degeneration of GIT), damaged ENS
*Insufficient fibre
*Insufficient fluids
*Drugs eg codeine
*Hypothyroidism, hyperCa2+
*Pregnancy
-Management :
*Eat fibre + drink fluids
*Find underlying cause eg drugs, medical condition
-Drugs :
Bulk-forming laxatives
Stimulant laxatives
Osmotic laxatives
Faecal softener laxatives

145
Q

Mechanism of bulk-forming laxatives eg methylcellulose, bran

A
  • act like fibre by absorbing water
  • softens stool + increases bulk
  • bowel distension
  • peristalsis
146
Q

Mechanism of stimulant laxative eg senna, bisacodyl

A
  • STIMULATE large intestine nerves
  • incease water + electrolyte secretion from colon
  • increased volume of stools
  • bowel distension
  • peristalsis
147
Q

Mechanism of osmotic laxative eg lactulose

A
  • contains substances that not absorbed/digested
  • so remain in gut lumen
  • substances hold water in stool by osmosis
  • maintains its volume
  • distension of colon
  • peristalsis
148
Q

Mechanism of faecal softeners eg docusate sodium(also stimulant laxative)

A
  • wetting + softening of stools by addition of water + fat

- improved peristalsis

149
Q

Control of vomiting

A

-Forcible ejection of stomach contents from mouth
-Controlled by 2 main brain centres in medulla oblongata vomiting centre + CTZ (chemoreceptor trigger zone)
VC :
-Initiates + controls retrograde GI contractions –> vomiting
-Responds to stimuli from various parts of body under stress/diseased
CTZ :
-stimulated by drugs + toxins
-stimulates VC to initiate emesis to remove toxin from body
-Also SNS activation: sweating, increased HR, pallor

150
Q

Causes of vomiting

A
GI infection
Distesion stomach or small intestine
Motion sickness
Drugs eg opioids
Increased pressure in skull eg tumour
Intense pain
Sight, smell, emotional circumstances
Pregnancy
151
Q

Vomiting

A

Loss of oodf, electrolytes (Na+, K+, Cl-, HCO3-), gastric acid (HCl), bile, blood
Results in :
-Hypovolaemia (dehydration)
-Metabolic alkalosis (due to loss of HCl)
-Malnutrition –> death
CVS adaptation, renal adaptation, behavioural (eg being thirsty so drinking more)

152
Q

Bismuth chelate

A
  • forms base over ulcer crater
  • adsorbs pepsin
  • causes HCO3- and prostaglandin secretion
  • protects gastric mucosa
  • Also toxic against H. pylori
  • But black tongue + stool
153
Q

How can NSAIDs contribute to ulcer formation?

A

=Non-steroidal anti-inflammatory drugs (eg ibuprofen)
Inhibit prostaglandin synthesis
-Prostaglandins protect stomach mucosa by :
*stimulating bicarbonate + mucus secretion
*inhibiting H+ secretion
*promoting vasodilation (blood flow to mucosa)
So drugs (eg celecoxib, rofecoxib) preferred as it blocks only COX-2

154
Q

Hemolytic Uremic Syndrome (HUS)

A

caused when EHEC E. coli strain enters blood + causes acute kidney failure (so high urea in blood – uraemia), haemolytic anaemia (destruction of RBCs so anaemia), thrombocytopaenia

155
Q

Patterns of blood flow?

A

Laminar : most vessels
Turbulent : ventricles, aorta, atheroma
Bolus : capillaries

156
Q

Darcy’s law

A

-About flow of fluid (blood)
-Flow = ∆Pressure / ∑Resistance
so BF = BP / TPR
BF = CO
so BP = CO x TPR

Q = P1–P2 / R
Q : Flow
P1-P2 : Pressure diff
R : Resistance to flow

Flow = Pa–CVP / TPR

157
Q

Bernoulli’s Law

A

Flow = Pressure (PV) + Kinetic (ρV2/2) + Potential (ρgh)

ρ : fluid mass

158
Q

Arterial Blood Pressure

A
  • Pressure exerted by blood on vessel walls (generated by left ventricular contraction)
  • Involves interactions between: systolic, diastolic, pulse, mean blood pressure
159
Q

TPR

A

Controls blood flow + pressure
Arterioles involved
Controlled by : Poiseuille’s law, Bayliss myogenic response

160
Q

Poiseuille’s Law

A

Resistance = 8ηL / πr^4

η : viscosity

161
Q

Veins

A
Thin-walled, collapsible, voluminous
Contain SM with symp innervation
Contain 2/3rd of blood volume
Act as reservoir
Useful in exercise + haemorrhage (*Starling’s law)
162
Q

Vasoconstrictor Nerves

A

Act directly on VSMCs
ONLY symp
NA acts on α1-receptors
Produces vascular tone (1 AP per sec)

163
Q

Vasoconstrictor hormones + where they act

A
-Act directly on VSMCs :
Adrenaline (α1-receptors)
Ang II (AT1 receptors)
ADH (V1 receptors)
Endothelin-1 (ETA1 receptors)
TXA2 (TP receptors)
164
Q

Mechanism of vasoconstrictor hormones

A
  • Stretch activates these receptors – myogenic response
  • receptors are Gq
  • linked to PLC
  • hydrolysis of PIP2 -> DAG + IP3
  • IP3 acts on SR to cause release of Ca2+
  • DAG increases excitability, gets more depolarised, activates vgcc, release of Ca2+
  • influx of Ca2+ from external fluid
  • Ca2+ activates Calmodulin
  • drives myosin light-chain kinase
  • phosphorylation of myosin heads
  • interaction between myosin-actin
  • contraction
165
Q

Vasodilator nerves

A

Act INDIRECTLY via endothelium
Symp + para
ACh/VIP act on endothelium, endothelium produces NO + PGI2 –> smooth muscle relaxation

166
Q

Vasodilator Hormones

A

-Act INDIRECTLY via endothelium :
Histamine (H2 receptors)
Bradykinin (B receptors)
Adrenaline (β2-receptors)

167
Q

How does NO cause vasodilation?

A
  • shear stress in endothelium (or IF) stimulates Nitric Oxide Synthase (eNOS)
  • produces NO
  • NO diffuses from endothelium cell into VSMC
  • stimulates G pathway
  • stimulates Guanulate Cyclase (GC)
  • produces cGMP from GMP
  • cGMP activates PKG
  • PKG causes vasodilation
168
Q

How does Prostacyclin (PGI2) cause vasodilation?

A
  • shear stress (or IF/Ach) on endothelium
  • membrane lipids into PGI2 via cyclooxygenase (COX)
  • PGI2 acts at Prostanoid receptor (PGI2) on VSMC’s
  • drives A pathway
  • Gs -> AC -> cAMP -> PKA
  • PKA causes vasodilation
169
Q

Catecholamines (A + NA)

A

More β2 in skeletal muscle + coronary vessels
A :
-higher affinity for β receptors
-vasodilation on skeletal + cardiac muscle
-vasoconstriction on other tissues
-give for actions on α1 (vessels) + β1 (heart) eg anaphylaxis
NA :
-higher affinity for α receptors
-vasoconstriction on skeletal, cardiac, others
-give for actions on α1 (vessels) eg heart failure - cardiac-protective

170
Q

Reflex Receptors

A

PRESSOR : switch ON reflexes (↑ CO, TPR, BP)
-Arterial chemoreceptors (aortic body, carotid body)
-Muscle metaboreceptors
-Nociceptive sympathetic afferents
DEPRESSOR : switch OFF reflexes (↓ CO, TPR, BP)
-Baroreceptors (aortic arch, carotid sinus)
-Ventricular mechanoreceptors

171
Q

Capillaries

A

Smallest diameter
Endothelium ONLY (1 cell thick)
Semi-permeable
Large SA (ideal for solute/fluid exchange)

172
Q

Solute transport

A

Solutes are exchanged by passive diffusion

  • Into cells : O2, glucose, AA, hormones, immune cells
  • Out cells : CO2, urea
173
Q

Fick’s law of diffusion

A

Js = - DAΔC / x
Js : mass per unit time
D : diffusion coefficient of solute – ease through solvent
A : area
ΔC / x : conc gradient (C1-C2) across distance x
negative value : flowing ‘down’ a conc gradient

174
Q

Types of capillaries

A
  • Continuous capillaries (least permeable) : in skin, CNS, muscle, lung
  • Fenestrated capillaries : in exocrine glands, glomerulus, intestinal mucosa
  • Discontinuous capillaries (most permeable) : in liver, spleen. bone marrow
175
Q

Glycocalyx

A

barrier so plasma proteins move from lumen into interstitial space via vesicle system not via intercellular spaces

176
Q

Lymphatic System

A

-Returns excess solutes/fluids back to CVS
-Lymph vessels have valves + SM
-Overall control of ECF balance depends on:
capillary filtration
capillary reabsorption
lymphatic drainage

177
Q

Factors that promote filtration vs reabsorption

A
FILTRATION
increased P꜀ 
increased πg 
increased Lₚ 
decreased πₚ 
REABSORPTION
decreased P꜀ 
increased πₚ
178
Q

Cell based model of coagulation

A
  • damaged tissue releases TF
  • TF activates 7a
  • 7a initiates thrombin required for amplification
  • 8a + 9a on platelet surface activates 10a
  • 10a has cofactor 5a
  • 10a + 5a induces prothrombin
  • prothrombin -> thrombin
  • thrombin induces fibrinogen -> fibrin
179
Q

Fibrinolytic system

A
  • endothelial cells release tPA
  • tPA activates plasminogen
  • plasminogen -> plasmin
  • plasmin breaks up clot
  • forming fibrin fragments + D-dimers
180
Q

Preload - Starling’s law

A

Energy of contraction of cardiac muscle is proportional to muscle fibers length at rest
-greater venous return
-stretch of muscle fibers
-more cross bridge formation
-increased sensitivity to Ca2+
-greater contraction
-greater SV
-SV increases in response to increase in volume of blood filling heart (end diastolic volume)
-Starlings predominates at low ventricular volumes
-Laplace’s predominates at high ventricular volumes
-Excess filling –> overstretched muscle –> decreased SV
so consider when fluid replacement

181
Q

Afterload – Laplaces Law

A

P = 2Sw / r or S = P x r / 2w

  • So radius proportional to wall stress
  • Opposes ejection of blood from heart + Starling’s at rest
  • Determined by wall stress through heart wall
  • Increases if pressure + radius increase
  • Decreases if wall thickness (explains hypertrophy in heart failure)
  • so Laplace good with small radius + bad with large
  • increased preload
  • increased chamber radius
  • increases afterload
  • In healthy heart - Starling’s law > Laplaces for maintained ejection
  • Facilitates ejection during contraction –>decreased chamber radius –>reduces afterload in ‘emptying’ chamber –> ejection during reduced ventricular ejection phase 4
  • In failing heart chambers dilated –> increased radius –>afterload–>reduced ejection
  • Increased arterial BP –>wall stress –> afterload –>reduced ejection
182
Q

Cardiac electrical cycle

A
  • SAN contraction generating nerve impulses
  • travel through heart wall
  • P wave (atrial contraction)
  • AVN (when impulses from SAN reach AVN – PR interval – short delay to allow full contraction of atria + emptying prior to ventricular contraction)
  • bundle of His splits into 2 bundle branches (go to either ventricles)
  • impulses carried down from centre of heart to ventricles
  • bundle branches taper into purkinje fibres
  • stimulate myocardial cells to contract
183
Q

ECG

A

P wave = atrial depolarisation
PR segment = AVN delay
QRS = ventricular depolarisation
ST segment = time which ventricles contract + emptying
T wave = ventricular repolarisation
TP interval = time which ventricles relax + filling

184
Q

SAN: Pacemaker potentials

A

Phase 4: Pacemaker potentials, If channels, hyperpolarisation activated Na channels
Phase 0: Depolarisation, Ca channels, influx via vgcc
Phase 3: Repolarisation, K Channels, efflux

185
Q

Atria/Ventricular action potentials

A
Phase 0: Na influx
Phase 1: Na channels close
Phase 2: Ca influx, plateau maintains refraction so no AP firing (allows proper filling + ejection)
Phase 3: K efflux
Phase 4: Na-K pump active
186
Q

Cardiac cycle

A

1) Diastole - ventricle filling, atrial contraction
- blood enters atria, moves into ventricles
- atria p > ventricles
- tri/bicuspid valves open
- filling aided by atria contraction
2) Systole - ventricular isovolumetric contraction
- ventricle p > atria
- tri/bicuspid valves close
- contraction on closed ventricle
- p ↑ in chamber
3) Diastole - eject, atrial filling
- ventricle p> aorta/pul artery
- aortic/pul valves open
- ejection
- blood also enter atria
4) Systole - ventricular isovolumetric relaxation
- aorta/pul artery p> ventricles
- aortic/pul valves close
- ventricle relaxes to receive blood

187
Q

Heart sounds

A

S1 - Lubb – Mitral + tricuspid close
S2 - Dubb – Aortic + pulmonary close
S3 - Turbulent blood flow into ventricles
S4 - Forceful atrial contraction against a stiff ventricle
Lubb = Start of ventricular systole
Dubb= Start of ventricular diastole

188
Q

Cardiac contraction

A
  • AP upstroke Na+ depolarises T-tubules
  • activates vgcc
  • local Ca2+ influx
  • Ca2+ binds to RyR on SR (close to T-tubules)
  • CICR
  • Ca2+ binds to troponin
  • displacement of tropomyosin/troponin complex
  • exposing active sites
  • myosin bind to active sites on actin
  • myosin head ATPase activity releases energy
  • ATP to ADP
  • slide filaments - contraction
189
Q

How does Ca2+ influence contraction

A

Greater rise in [Ca2+]i -> more sites exposed -> more crossbridges -> more contractility - inotropic effect

  • Shortening of the sarcomere.
  • Z disc distanceshortens
  • H zonedisappears
  • Dark A bandincreases due to overlap
  • Light I bandshortens.
  • myosin head attaches to actin (high energy ADP + P configuration)
  • power stroke: myosin head pivots pulling actin filament toward center
  • cross bridge detaches when new ATP binds to myosin
  • tilting of myosin head when ATP hydrolysed
  • another cross bridge can form
  • decrease [Ca2+]
  • blocking of actin site by tropomyosin
190
Q

Ca2+ removal

A
  • K+ stimulated T-tubule repolarisation
  • vgcc closes
  • no Ca2+ influx or CICR
  • decrease [Ca2+] via Na+/ Ca2+ exchanger (30%)
  • Ca2+ SR uptake via Ca2+ ATPase (SERCA)
  • mitochondrial Ca2+ uptake
191
Q

Cardiac glycosides

A
  • Inotrope = Agents that alters force of contraction eg Digoxin
  • blocks Na/K-ATPase
  • more Ca2+ taken into SR
  • more Ca2+ released upon next depolarisation
  • Decrease rate of contractions by acting on Na/K-ATPase pump
192
Q

Digoxin

A
  • potent inhibitor of Na/K/ATPase
  • which pumps sodium out + potassium into cell
  • [Na]i to increase
  • decreases activity of Na/Ca exchanger
  • less Ca2+ pumped out of cell thus
  • more [Ca2+]i
  • more Ca2+ to bind to TnC
  • increases contractility – inotropy
193
Q

Symp NS on contractility

A

-stimulation of β1-adrenoceptor
-increases PKA :
*PKA phosphorylates vgcc –>increases contractility
*PKA phosphorylates K+ channels + SERCA –>increased relaxation
Diastolic time maintained allowing time for ventricle filling + coronary perfusion

194
Q

Diff between force of contraction vs contractility

A
  • Force of contraction effected by preload (volume of venous return) + contractility
  • Contractility depends on how much [Ca2+]i
195
Q

Heart failure

A

=Clinical syndrome where heart unable to maintain sufficient blood flow to meet body’s needs
Structural/functional disorder impairs ability of ventricle to fill/eject blood
-increased ventricular filling
-increased contractility
-increased SV
-eventually plateau
-overstretching of ventricles
-decreased contractility
-reduced ability to cross link actin-myosin filaments
Causes of HF = ischaemic heart disease, myocarditis, toxic:alcohol, chemotherapy, muscular dystrophies, glycogen storage diseases
DIAGNOSIS
BNP (released when muscle is strained) cleaved to NTProBNP + BNP – means NtproBNP as it’s more stable
If elevated then ECG
-Commonest cause for emergency admissions in over 65’s
-Men > women
-Estimated to increase by 50% by 2030
Risk factors :
smoking, previous MI, hypertension, diabetes, abdominal obesity, psychosocial stress, high ApoB: ApoA ratio
(ApoB + Apo A are apolipoproteins involved in lipid transport, ratio indicates cholesterol, if low good)

196
Q

Compensatory mechanism of heart failure

A
  • Preload reduced by vasodilators (GTN) to reduce load of heart by dilating peripheral vasculature + diuretics
  • Maintain SV (dilation) to increase SV (starling’s law) - only maintained temporarily until pressure in stretched ventricle increased –> restriction to filling + increased venous pressures
  • Increase HR when SV falls to maintain CO temporarily (so new MI patient tachycardic) so decrease heart blood volume to decrease afterload because with dilated heart there’s afterload for a given arterial pressure (La Place’s law)
197
Q

Coronary circulation

A
  • Coronary arteries arise from ascending aorta
  • Right side: right coronary artery, right marginal artery, posterior interventricular artery
  • Left side: Left coronary artery, circumflex artery, anterior inter-ventricular artery (LAD)
  • All drain into RA via coronary sinus
  • Functional end arteries = no collateral supply
198
Q

Right vs left heart failure

A

SYMPTOMS
-Right ventricular failure = back pressure in RA -> pressure in SVC + IVC -> increases JVP -> oedema, right and left pleural effusion, ascites (swelling in abdomen)
-Left Ventricular Failure = Back pressure into LA + pulmonary veins :
*pulmonary oedema (leak of fluid into alveoli)
*dyspnoea (shortness of breath)
*orthopnoea (worse when lie flat due to increased oncotic pressure when lying down)
*paroxysmal nocturnal dyspnoea (sudden shortness of breath at night
Both simultaneously = congestive heart failure

199
Q

Classification of heart failure

A

-Reduced EF vs Preserved EF (Ejection fraction is proportion of blood that leaves heart every time it contracts)
-Acute vs Chronic
-Left vs Right Ventricular failure
-NYHA classification scale :
Class 1 = No limitations
Class 4 = Breathless at rest, unable to carry out any physical activity without discomfort

200
Q

What happens during heart failure

A

Starling’s Law:
-Myocyte damage = reduced ability to contract
-Less blood pumped out into circulation so less coming back
-Lower preload = Starling’s law breaks down
Laplace’s Law :
-Reduced energy of contraction = afterload harder to overcome
-Effect of Laplace’s law increases as more pressure needed to push blood out of heart
-SV + CO decrease –> low cardiac perfusion –> ischaemia –> HF

201
Q

Ventricular Dilatation

A
  • muscle fibres stretch
  • increases contractility - Starlings law
  • increases ventricular volume
  • increased EDV
  • Increases ventricular volume –> increased EDV
  • Increases contractility because when fibres unstretched, mechanical interference between overlapping fibres reduced, so potential for cross bridge formation increased –> Starling’s
202
Q

Myocardial hypertrophy

A

Increasing wall thickness :
-Increases force of contraction since more sarcomeres present to contract –> increases CO
-Reduces wall stress (wall stress + wall thickness inversely proportional) –> increases CO
BUT
-Hypertrophy = increased metabolic demand so difficult to sustain its own supply –> heart failure

203
Q

Neurohormonal compensations - RAAS

A
  • low BP activates RAAS
  • juxtaglomerular cells release renin into bloodstream
  • converts angiotensinogen -> Ang I
  • Ang I transported to lungs
  • Ang I -> Ang II by ACE
  • Ang II = reabsorption of Na+/H2O + contraction of vessels
  • constriction of arterioles increases TPR + BP
  • so blood faster around body
  • increased reabsorption of Na+/H2O –> increase preload, EDV, SV, CO

BUT

  • Vasoconstriction increases afterload,
  • Increased CO = Increased preload
  • Both increases cardiac work
204
Q

Neurohormonal compensation - symp drive

A
  • decreased CO detected by baroreceptors
  • central + peripheral chemoreflex activation induce A, NA, VP release
  • adrenergic activation increases HR + contractility via vasoconstriction
  • increased afterload
  • increased cardiac work
  • myocyte damage
205
Q

Treatment of heart failure

A

Treatment : TRIPLE THERAPY
-ACE inhibitor eg senalpril, losartan, elanapril
-β-blockers - negative inotrope cause less contractility so less adrenaline binding to β2 = less symp drive so decrease HR + BP
-Aldosterone antagonist eg losartan, decrease vascular resistance so decrease BP
Other options : heart transplant, left ventricular assist devices (external cardiac pumps), biventricular pacing

206
Q

What happens to our coronary vessels when we run?

A
  • During exercise, heart beast stronger, faster
  • Increased cardiac demand
  • Coronary vessels vasodilate to meet these demands
  • More BF to heart tissue
207
Q

Angina pectoris

A
  • Crushing chest pain
  • Narrowing/blockage of coronary artery = O2 demand exceeds supply
  • Stable = Predictable, chest pain on exertion
  • Unstable = Chest pain due to thrombus formation
  • Variant (Prinzmetal) = Vasospasm of coronary arteries, causes chest pain at rest
208
Q

Stable angina

A
  • At rest coronary vessels maximally vasodilated
  • Further exertion will lead to an increase in cardiac demand
  • Demand > supply –> ischaemia
  • Ischaemic products stimulate symp nociceptive afferents = chest pain
209
Q

Risk factors + treatment

A
Risk factors for angina :
High BP
Tachycardia
Increased force of contraction 
Cold weather
Large meal 
Treatment for angina :
Nitrates 
Beta blockers
Calcium channel blockers
Antiplatelet drugs
210
Q

Myocardial Infarction

A
  • Tissue death as a result of vascular occlusion
  • ST elevation on ECG
  • As opposed to angina has ST depression
211
Q

Development of heart

A
  • 4 chambered heart tube forms
  • cardiac looping
  • AV canal divides into right and left channels
  • atrial septa forms
  • conotruncal cushion forms leading to division of outflow tract
212
Q

Patent Foramen Ovale

A
  • In foetus, circulation doesn’t need to go through lungs
  • gets O2 from placenta
  • blood in foetal heart shunted straight from RA to LA
  • hole in interatrial wall = foramen ovale allows for this
  • Normally closes up after birth
  • Patent foramen ovale = doesn’t close
213
Q

Ventricular Septal Defect

A
  • Most common congenital heart defect
  • Hole in interventricular septum
  • Left side of heart has higher pressure than right side
  • Oxygenated blood from left side passes to right side, mixed with deoxygenated blood
214
Q

Tetralogy of Fallot

A

Overriding aorta
Pulmonary stenosis
Ventricular septal defect
Right ventricular hypertrophy

+ VSD both common in Down’s syndrome

215
Q

EQUATIONS

A
CO = HR x SV
SV = EDV – ESV
EF = SV / ESV
BP = CO x TPR
Velocity = blood flow / CSA
Pulse pressure = systolic - diastolic
Mean arterial pressure = diastolic x (1/3 pulse pressure)
Stroke work = change in ventricular pressure x change in volume
216
Q

Anatomy of pituitary gland

A

-Sits in sella turcica within sphenoid

Cell types = Chromophobes + Chromophils
-Chromophils :
Acidophils - GH + prolactin
Basophils - TSH, ACTH, LH, FSH

217
Q

Development of pituitary gland

A

Embryologically :

  • Anterior pituitary develops from Rathke’s pouch (part of oropharyngeal ectoderm)
  • Posterior pituitary + pituitary stalk develop from part of neuroectoderm
  • Finger of ectoderm grows upward from mouth roof =Rathke’s pouchand becomes ANTERIOR pituitary or adenohypophysis
  • Finger of ectodermal tissue evaginates ventrally from diencephalon of developing brain - extension of ventral brain becomes POSTERIOR pituitary or neurohypophysis
218
Q

Hormones of pituitary

A

Ayy Ohh, it’s the FAT GP
Posterior :
ADH - retains water
Oxytocin - uterine contraction + breast milk release

Anterior :
FSH + LH - reproductive control
ACTH - regulates adrenal cortex
TSH - controls production of thyroid hormones
GH - controls growth (releases IGF-1 cause bone + muscle growth)
PRL (prolactin) - breast milk production

219
Q

eg of hypothalmic factor

A

TRH, CRH, LHRH

220
Q

Prolactin

A

Has diff control to all pituitary hormones :

  • Tonic release of DA inhibits prolactin release
  • Positive feedback
221
Q

Prolactinoma

A

Features of prolactin excess (hypogonadism):
Infertility, Amenorrhea, Impotence, reduced libido.

TREATMENT:
Dopamine agonists, Cabergoline, Bromocriptine
NOT surgery

222
Q

Non-functioning pituitary tumours

A

-30% of all pituitary tumours
-No symptoms of hormone excess production
-Cause symptoms due to space occupation :
Headache
Visual field defects (bitemporal hemianopia)
Nerve palsies
Interfere with rest of pituitary function
-Treatment :
Surgery + Radiotherapy
No effective medical therapy

223
Q

Pituitary Function with an Expanding Tumour

A
  • Lose function based on biological importance

- Prolactin levels INCREASE due to compression of pituitary stalk

224
Q

Treating pituitary adenomas

A

Surgery - Transphenoidal.
Radiotherapy - slow.
Drugs - Block hormone production and release.

225
Q

Hypopituitarism

A
Treatment = replace what is lacking
Thyroid -> thyroxine
Sex steroids –> Testosterone, oestrogen
Reduced cortisol -> Hydrocortisone
Reduced GH -> Growth Hormone
226
Q

Diabetes insipidus

A
Underproduction of ADH :
-Cranial - lack of production 
-Nephrogenic - receptor resistance
Diagnosis :
-Polyuria (>3l)
-Polydipsia
-Plasma Na+  INCREASE
-Plasma osmolality  INCREASE
-Urine osmolality  DECREASE
-Urine Na+  DECREASE
Investigation :
-Water Deprivation test – STOP if patient drops 3% their body weight
-Normal = small amount of conc urine
-DI = large amount of dilute urine 
-desmopressin (DDADH) test (mimics ADH) :
*cranial DI = urine production stops
*nephrogenic DI = still produce urine
227
Q

SIADH

A
Excess ADH from :
-Brain injury/infection
-Lung Cancer/infection asthma IPPV
-Metabolic : hypothyroidism, Addisons
Low serum osmolality, low serum Na conc, high urine osmolality, high urine Na conc
228
Q

Thyroid hormones

A

T4: major form released to blood, less active (prohormone)
T3: active form, converted in target cells
T4 -> T3 by deiodinases (removes one of iodine’s)

229
Q

Thyroid hormone synthesis

A
  • follicular cells make thyroglobulin in ER
  • released into colloid by exocytosis via apical membrane
  • iodide taken up from blood into follicular cell via Na/I symporter on basolateral membrane
  • transported into colloid via pendrine cotransporter
  • transports Cl- in and I- out
  • TPO converts 2I-s -> I2
  • TPO also iodinates thyroglobulin
  • forms MIT or DIT groups - moniodotyrosine or diiodotyrosine
  • TPO conjugates tyrosine residues
  • form T4, T3, RT3 (biologically inactive)
  • iodinated + conjugated thyroglobin moves back into cell by endocytosis
  • lysosomes bind to vesicle + cleave peptide bonds
  • so T3 + T4 separated off
  • move into blood via MCT receptor on basolateral membrane
  • most T3 + T4 bound to TBP, albumin – for transport + increases half-life
  • T3 + T4 diffuse into tissues via MCT
  • T4 (inactive) -> T3 (active) via deiodinases
230
Q

Functions of TH

A

Increase metabolic rate :
-Number + size of mitochondria, enzymes in metabolic chain, Na/K-ATPase activity
-Positive inotropic, chronotropic effects on heart
-Synergizes with symp NS
Energy metabolism :
-Partially antagonizes insulin signalling
-Gluconeogenesis, lipolysis
Growth + development

231
Q

Control of TH synthesis

A
  • Controlled by the HPT axis

- TRH released into portal circulation -> ant pit gland -> stimulates thyrotrophs to secrete TSH

232
Q

Actions of TSH

A
  • Increases iodine uptake
  • Stimulates TPO reaction involved in TH synthesis
  • Stimulates uptake of colloid
  • Induces growth of thyroid gland —> goitre
233
Q

Hypothyroidism

A

-TH deficiency
-High TSH
-Low T3, T4
Primary Hypothyroidism (Hashimotos disease) :
-Autoimmune thyroid destruction
-Low TH, high TSH
-Lethargy, intolerance to cold
-Diffuse goitre
-Lack of growth + development
Secondary hypothyroidism so all low
-From deficient TSH secretion from cellar lesions eg pituitary tumor or craniopharyngioma
Causes:
-Hashimotos
-Post-thyroidectomy (due to previous hyperthyroidism)
-Post RAI (radioactive iodine)
-Iodine deficiency
Investigations:
-Test TSH + T3/4 levels
-Test for TPO activity
Treatment: Levothyroxine

234
Q

Hyperthyroidism

A

Primary: thyroid gland problem
Secondary: pituitary regulation problem so all high
-Low TSH
-High T3, T4
Primary Hyperthyroidism (Graves disease) :
-Autoimmune
-High TH, low TSH
-Weight loss, tachycardia, fatigue
-Diffuse goitre (TSH receptor stimulation)
-Vitiligo
-Opthalmopathy : exopthalmos, periorbital oedema, lid retraction/lid lag, ophthalmoplegia
Antithyroid medications (Block TPO enzyme):
Carbimazole
Methimazole
Propylthiouracil
Thyroid Storm – Extreme thyrotoxicosis (due to stressful illness or thyroid illness)
Symptoms: delirium, severe tachy, vominting, diarrhoea, dehydration, high fever

235
Q

Adrenal steroidogenesis

A
  • cholesterol into zona glomerulosa
  • cholesterol -> pregnenolone
  • pregnenolone could :
  • Stay in cell + converted to progesterone
  • Enter back into blood + move down to zona fasiculata under action of new enzyme become a new molecule
236
Q

Types of Steroids

A

-Mineralocorticoids – Aldosterone
-Glucocorticoids – Cortisol
Metabolism – prevent fatal hypoglycaemia
Immune function
-Androgens – Sex steroids
Testosterone

237
Q

Role of cortisol

A
-Increases Plasma Glucose Levels
INCREASE in Gluconeogenesis
INCREASE in Glycogenesis
INCREASE in Glycogen Storage
DECREASE in Glucose Utilisation 
-Proteins are broken down so AA released
-Increased Lipolysis
-Na+ and H2O Retention (Maintains BP)
-Anti-Inflammatory (inhibits AA production + COX activity)
-Increased Gastric Acid Production
238
Q

Cushing’s Syndrome

A

Excess GC/cortisol in the blood
Adenoma producing ACTH in pituitary gland

-Changes in protein + fat metabolism :
Change in body shape
Central obesity 
Moon Face
Buffalo Hump
Thin skin, easy bruising
Osteoporosis
Diabetes
-Salt + Water Retention :
High blood pressure
Fluid retention
-Changes in sex hormones :
Excess Hair Growth
Irregular periods
Problems conceiving
Impotence
TREATMENT :
-Localisation + removal of tumour – adrenal, pituitary or ectopic ACTH tumour (often SC lung tumour). If single adrenal tumour, then short term steroid replacement therapy required after surgery  
-Cortisol Production Blockers: If can't have surgery
239
Q

ACTH receptor

A
  • Part of melanocortin group of receptors
  • ACTH can bind to other melanocortin receptors instead
  • One of the other receptors controls skin pigmentation
  • Excess circulating ACTH can affect skin pigmentation (eg in Addison’s)
240
Q

Muscles of Inhalation

A
Quiet/resting Inhalation:
-diaphragm forms floor of thoracic cavity
-contracts + flattens
-increase vertical diameter of thoracic cavity 
-contraction pulls + expands lungs
Heavy/forceful Inhalation:
-external intercostals contract 
-accessory muscles
-SCM
-3 scalenes
241
Q

Movement of Ribs

A

PUMP HANDLE : Elevation of ribs to increase in antero-posterior diameter of thoracic cavity
BUCKET HANDLE MOVEMENT : Elevation of ribs to increase lateral diameter of thoracic cavity

242
Q

Muscles of Exhalation

A

Quiet Exhalation - passive :
-lung elastic recoil
-inspiratory muscles relax: diaphragm, external intercostals, ribs depress
Forceful Exhalation :
-contraction of internal intercostals
-pull ribs inferiorly
-contraction of abdominal muscles (rectus abdominis) because elastic recoil of lungs reinforced by contraction of the abdominal muscles so force abdominal contents against diaphragm, pushing it up
-increased pressure in abdominal region + thorax so air rushes out

243
Q

Lung volume definitions

A

VT – tidal volume (varies with breathing pattern)
volume of air moved into or out of the lungs during quiet breathing

IRV – inspiratory reserve volume

  • extra volume that can be inspired after breathing in tidal volume
  • extra volume of lung you have if you want to take a deep breath (during exercise)

ERV – expiratory reserve volume

  • extra volume that can be expired after breathing out tidal volume
  • maximal volume of air that can be exhaled from the end-expiratory position

VC –vital capacity
*volume of air breathed out after maximal inhalation

RV – residual volume (can’t blow this out)

  • volume of air remaining in lungs after maximal exhalation (VC)
  • because you can’t collapse lungs anymore or push your ribcage down any further

FRC – Functional residual capacity

  • volume in lungs after breathing out tidal volume (at the end of a normal breath out).
  • it’s ERV + RV

TLC – Total lung volume
*volume in lungs at maximal inflation, sum of VC and RV.

244
Q

Factors that Effect Air flow

A

Lung Compliance

Lung Resistance

245
Q

Lung compliance

A

=ability of lungs to inflate
=ratio of change in lung volume : change in transpulmonary pressure
so alveolar pressure - intrapleural pressure
High compliance: easily expanded
Low compliance: resist expansion
Lung compliance = ΔV / ΔP

Is a feature of the small airways (alveoli)
Certain disease states alter lung compliance

246
Q

Elastin compliance

A

-When lungs expand, elastin stretches
-Alveoli have elastin
Fibrosis: elastin replaced by collagen (fibrous) eg silicosis, asbestosis
-Emphysema (COPD) :
Breakdown of alveolar walls
Degraded elastin
HIGH compliance so easy for lungs to distend but they empty slowly so lungs become chronically over-inflated and have a reduced capacity to recoil

247
Q

Compliance - Surfactant

A
  • Lowers surface tension of water
  • Prevents alveolar collapse : when diameter of alveoli decreases, surfactant molecules pack together so alveoli stabilised + don’t collapse
  • When surfactant is reduced/absent : increased surface tension of fluid lining alveoli so decreased compliance
248
Q

Airway resistance

A

Anything that decreases diameter increases airway resistance
eg :
-Oedema – vessels leak fluid
-Asthma – bronchoconstriction, mucus plugging, inflammatory oedema
-COPD (bronchitis) – pathological remodelling of the airway, mucus plugging

249
Q

Unconscious Neural Control of Breathing

A

Respiratory pattern generator (RPG) within medulla – oscillator
Main players:
-Dorsal respiratory group = mainly inspiratory neurons for inspiration initiation
-Ventral respiratory group = in medulla, inspiratory and expiratory neurons for finishing inspiration and expiration, send impulses to phrenic + intercostal nerve supplying external intercostals

250
Q

Muscle innervation of breathing

A
Phrenic nerve (C3-5) = diaphragm
Phrenic nerve (T1-12) = intercostal nerves
251
Q

Conscious Neural Control of Breathing

A

Cortical override

252
Q

Control of breathing

A

Central chemoreceptors :
-Respond to changes in CSF pH
-In medulla
-Respond to changes in H+/HCO3- so indirectly detecting changes in [CO2]
Peripheral chemoreceptors :
-PO2, PCO2, pH
-In carotid bodies monitorppwithin arterial vessels
-Links to RPG via CN IX (glossopharyngeal nerve)

[aortic body, located onaortic arch, monitors [O2] closer toheart]

253
Q

Drives of breathing

A

Hypercapnic drive - regular regulator of breathing :
-Increased CO2/H+ by hypoventilation –> acidosis
-Sensed by central + peripheral chemoreceptor
Hypoxic drive :
-Sensed by peripheral chemoreceptors
-Used when Low PaO2 (below 8kPa – normal =13)

254
Q

Gas Exchange

A
  • oxygen enters airways via inspiration -> alveolar sacs
  • diffuses across alveolar membrane + pulmonary capillary endothelial cells, into blood
  • transported to cells for respiration – oxidative phosphorylation.
  • transported around body in blood by binding to Hb
  • CO2 produced from cellular respiration
255
Q

Conditions for maximal diffusion rate

A
1. High partial pressure gradient; 
Hypoventilation + hypoperfusion affect this 
2.  High SA
Emphysema reduces SA
3. Short distance
Fibrosis increases membrane thickness
256
Q

Alveolar gas equation

A

PAO2 = F₁O2 x (PB - PH2O) - (PaCO2/RER)

F₁O2 : O2 content of inspired air
PB : 100kPa - sea level
PH2O : 6kPa - humidified air

PAO2 : alevolar content
F₁O2 x (PB - PH2O) : O2 inspired (19.74)
(PaCO2/RER) : O2 consumption

257
Q

Bohr Effect

A
  • increased partial pressure of oxygen –> increased oxyhaemoglobin saturation,
  • Left shift = less partial pressure of oxygen required to saturate Hb eg increased pH, reduced 2-3 DPG
  • Right shift = partial pressure of oxygen in more demand to saturate Hb so oxygen affinity less so you need increased 2-3 DPG + decreased pH
258
Q

Numbers for lung

A
pH 	(7.35 - 7.45)
PaO2 	(10.6-13.3kPa)
PaCO2 	(4.9-6.1kPa)
Nitrogen		79%
Oxygen		21%
Carbon dioxide	0.04%
259
Q

Effect of hypoxia

A

Hypoventilation
Diffusion Defect
Shunt
V/Q mismatch

260
Q

Hypoventilation from hypoxia

A
  • Only cause of hypercapnia (high CO2) + hypoxemia caused by inability to exhale CO2 + inhale O2
  • Low O2 / high CO2
  • Causes: obesity, (difficult to expand chest), sleep apnoea (intermittent airway obstruction)
261
Q

Diffusion Defect from hypoxia

A

Caused by changes in Ficks law eg SA, conc gradient

Seen in emphysema (COPD) and fibrosis

262
Q

V/Q mismatch

A
  • problems with ventilation or lung perfusion eg pulmonary emboli or obstruction of bronchi
  • pulmonary vasoconstriction to divert blood away from this area of V/Q mismatch
  • to become oxygenated.
  • area in which it left, where there was V/Q mismatch is :
  • ‘physiological dead space’.
  • Supplemental oxygen can help
  • Norm ventilation = 5L/min
263
Q

Shunt from hypoxia

A
  • FULL LUNG BLOCKAGE – perfusion without ventilation
  • when perfusion without ventilation eg pneumonia
  • deoxygenated blood leaving RHS of heart returns to LHS without being oxygenated
  • Supplemental O2 WON’T help
  • Low O2/ norm or high CO2
264
Q

Respiratory failure

A
Type 1 :
-Low PaO2 / normal PaCO2 
-Caused by V/Q mismatch
-Hypoxemia + normal CO2 
-Although normal Pa02 range is 10.6-13.3kPa,  not in respiratory failure until drops below 8 kPA.
Type 2 :
-Low PaO2  / high PaCO2
-Caused by full shunt
-Hypoxemia + hypercapnia
265
Q

Restrictive vs. Obstructive

A
Obstructive : 
-FEV1/FVC < 70%
-COPD + asthma
Restrictive : 
-FEV1/FVC > 80%
-Interstitial lung disease where lung fibrosis
266
Q

Haldane Effect

A
  • venous blood carries more CO2 than arterial blood
  • due to deoxyhaemoglobin having higher affinity for CO2 + H+ than oxyhaemoglobin
  • as oxyhaemoglobin dissociated with oxygen by the time come into arterial blood from offloading at tissues
  • then more deoxy Hb in venous blood
  • Hb doesn’t saturate with CO2
  • deoxyHb buffers pH so CO2 can dissolve in blood + bind to Hb
267
Q

Asthma

A

=chronic, inflammatory obstructive disease
-Reversible airflow limitation + bronchial hyperresponsiveness
Symptoms :
wheezing, breathlessness, coughing, diurnal variation (so more prevalent either early morning or late at night)
Pathophysiology :
-Increased SM
-Alveolar oedema (due to inflammation where alveolar membrane more permeable)
-Increased goblet cells which limit airway flow + airway resistance
-Plasma leakage in alveoli
Can be split into extrinsic or intrinsic asthma :
Extrinsic: Known triggers
Intrinsic: No known triggers

268
Q

COPD

A
Emphysema (loss of elastin in alveoli)
Chronic inflammation
Obstructive not Restrictive 
-Decreased ventilation – alveolar hypoxia
-Decreased lung recoil – increased expiratory effort
-Overall = hypoxaemia
Treatment: 
Anti-mus
β-agonists